|
LDHA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.129600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.903200E-01 |
| Normal-vs-Stage2 |
1.693440E-01 |
| Normal-vs-Stage3 |
2.683800E-02 |
| Normal-vs-Stage4 |
1.667740E-02 |
| Stage1-vs-Stage2 |
6.899600E-02 |
| Stage1-vs-Stage3 |
3.367800E-02 |
| Stage1-vs-Stage4 |
8.843700E-03 |
| Stage2-vs-Stage3 |
6.103900E-03 |
| Stage2-vs-Stage4 |
2.457000E-03 |
| Stage3-vs-Stage4 |
5.821600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.473900E-02 |
| Normal-vs-AfricanAmerican |
5.484400E-01 |
| Normal-vs-Asian |
3.046200E-01 |
| Caucasian-vs-AfricanAmerican |
8.629000E-01 |
| Caucasian-vs-Asian |
9.803400E-01 |
| AfricanAmerican-vs-Asian |
8.996800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.717600E-01 |
| Normal-vs-Female |
2.611400E-01 |
| Male-vs-Female |
7.974600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.356200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.116400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.904000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.180420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.195200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.263000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.761900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.423200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.146370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.169410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.352150E-04 |
| Classical-VS-Follicular |
2.22044604925031E-16 |
| Classical-VS-Other |
2.137700E-02 |
| Classical-VS-Normal |
3.337300E-03 |
| Tall-VS-Follicular |
2.53130849614536E-14 |
| Tall-VS-Other |
9.772700E-04 |
| Tall-VS-Normal |
2.17929999999367E-05 |
| Follicular-VS-Other |
5.737200E-01 |
| Follicular-VS-Normal |
2.41109999965516E-07 |
| Other-VS-Normal |
5.264100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.091800E-01 |
| Normal-vs-N1 |
1.090200E-01 |
| N0-vs-N1 |
1.879530E-02 |
|
|
